The Prohibited List is updated annually following an extensive consultation process facilitated by WADA.
What is the Prohibited List?
The Prohibited List (List) was first published in 1963 under the leadership of the International Olympic Committee. Since 2004, as mandated by the World Anti-Doping Code (Code), WADA is responsible for the preparation and publication of the List.
The List is a cornerstone of the Code and a key component of harmonization.
It is an International Standard identifying substances and methods prohibited in-competition, out-of-competition and in particular sports.
Substances and methods are classified by categories (e.g., steroids, stimulants, gene doping).
The use of any prohibited substance by an athlete for medical reasons is possible by virtue of a Therapeutic Use Exemption (TUE).
How is the List updated?*
Guidelines for the annual review and consequent publication of the List are outlined in the Code.
WADA's role is one of facilitator of the consultation process.
The agreed process for the annual consideration of the List includes three meetings (see timeline below) of WADA's List Expert Group with a draft discussion List being published and circulated for consultation in June, following the second meeting.*
At its third meeting in September, the List Expert Group, following consideration of the submissions received from the consultation process, recommends the new List to the Health, Medical and Research Committee which in turn makes recommendations to WADA's Executive Committee.
The Executive Committee finalizes the List at its September meeting.
The updated List is published by October 1 and comes into effect on January 1 the following year.
What is the role of WADA's List Expert Group?
The List Expert Group is a panel of scientists chosen for their international expertise.
It is a subgroup of WADA's Health, Medical and Research Committee.
The List Expert Group meets three times each year.
The List Expert Group makes recommendations on the contents and revisions to the Prohibited List.
List Revision Timeline*
January/February First meeting of the List Expert Group to define new and key areas of activities and allocate tasks.
April Second meeting of the List Expert Group to prepare the Draft List.
June - July Draft List circulated to stakeholders (government and sport movement) for consultation and comment.
August Stakeholder comments received; Integration of relevant comments into the Draft List; Draft List circulated to List Committee.
September Third meeting of the List Expert Group to review comments and Draft List; Draft List circulated to the WADA Health, Medical and Research Committee for discussion and final recommendation; Circulation of the List to the WADA Executive Committee for discussion and approval.
October Publication of the updated List which comes into effect on January 1 the following year.
January The updated List comes into effect on January 1.
* This description of the process for reviewing and updating the Prohibited List is for information only. WADA reserves the right to deviate from this process and in no way any such deviation could be construed as invalidating the List.
Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on this website. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this Website is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. ProLine Sports Nutrition, Inc. ®